IP Verse

Eli Lilly and Company v. Teva Pharmaceuticals International GmbH et al. - IPR2022-00796

Explore the PTAB proceeding IPR2022-00796 filed by Eli Lilly and Company against Teva Pharmaceuticals International GmbH et al. on Apr 11, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2022-00796
Filing Date
Apr 11, 2022
Petitioner
Eli Lilly and Company
Respondent
Teva Pharmaceuticals International GmbH et al.
Status
Final Written Decision
Respondent Application Number
15712444
Respondent Tech Center
1600
Respondent Patent Number
10392434
Institution Decision Date
Oct 14, 2022
Termination Date
Oct 11, 2023

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2022-00796.

TypeName
Petitioner CounselFeldstein, Market al
Respondent CounselEllison, Eldoraet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.